BioNexus Gene Lab Corp Common stock Price Chart
BioNexus Gene Lab Corp Common stock Volume Chart
BioNexus Gene Lab Corp Common stock Market Segments
After Hours
-0.04(-1.74%)
| Open | $2.20 |
|---|---|
| Close | $2.16 |
| Low | $1.88 |
| Low Change | -0.32 (-14.48%) |
| High | $2.20 |
| High Change | +0.00 (+0.08%) |
| Range | $0.32 |
| Volume | 5.066K |
| Dollar Volume | $10.94K |
Regular Trading Hours
-0.05(-2.25%)
| Open | $2.22 |
|---|---|
| Close | $2.17 |
| Low | $2.14 |
| Low Change | -0.08 (-3.60%) |
| High | $2.22 |
| High Change | +0.00 (+0.00%) |
| Range | $0.08 |
| Volume | 7.31K |
| Dollar Volume | $15.86K |
Premarket
+0.07(+3.20%)
| Open | $2.19 |
|---|---|
| Close | $2.26 |
| Low | $2.19 |
| Low Change | 0.00 (0.00%) |
| High | $2.26 |
| High Change | +0.07 (+3.20%) |
| Range | $0.07 |
| Volume | 1.1K |
| Dollar Volume | $2.49K |
After Hours Yesterday
+0.00(+0.00%)
| Open | $2.18 |
|---|---|
| Close | $2.18 |
| Low | $2.18 |
| Low Change | 0.00 (0.00%) |
| High | $2.18 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 350 |
| Dollar Volume | $763.67 |
Regular Trading Hours Yesterday
+0.02(+0.68%)
| Open | $2.21 |
|---|---|
| Close | $2.22 |
| Low | $2.21 |
| Low Change | 0.00 (0.00%) |
| High | $2.22 |
| High Change | +0.02 (+0.68%) |
| Range | $0.02 |
| Volume | 2.9K |
| Dollar Volume | $6.44K |
Premarket Yesterday
*No Trades in Segment
BioNexus Gene Lab Corp Common stock Moving Averages
| 5 Day Moving Average (SMA5) | $2.24 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.22 |
| 20 Day Moving Average (SMA20) | $2.25 |
| 50 Day Moving Average (SMA50) | $2.34 |
| 100 Day Moving Average (SMA100) | $2.98 |
| 200 Day Moving Average (SMA200) | $4.13 |
BioNexus Gene Lab Corp Common stock Statistics
| Average Volume (30 Days) | 4.34K |
|---|---|
| P/E Ratio (Current) | -1.80 |
| EPS (Current) | -$1.23 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$1.88M |
| Cash Ratio | 4.57 |
| Current Ratio | 10.46 |
| Quick Ratio | 9.16 |
| Debt to Equity | 0.00 |
| Enterprise Value | $2.98M |
| EV to EBITDA | -0.92 |
| EV to Sales | 0.40 |
| Price to Book | 0.62 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 0.72 |
| Return on Assets | -0.32% |
| Return on Equity | -0.35% |
BioNexus Gene Lab Corp Common stock Stock Splits
There have been 2 stock splits for BioNexus Gene Lab Corp Common stock (BGLC). The last reverse stock split occured on April 7, 2025 and reduced the outstanding shares at a ratio of 10:1.
| Date | Type | Ratio |
|---|---|---|
| Apr 7, 2025 | Reverse | 10:1 |
| Jul 20, 2023 | Reverse | 12:1 |
BioNexus Gene Lab Corp Common stock Dividends
There have been no dividends for BioNexus Gene Lab Corp Common stock (BGLC).